Company lists
The San Francisco edition · 2026

Life sciencescompanies in San Francisco

Life sciences technology, genomics, oncology, platforms and tools, startups and more: the companies building life sciences in San Francisco, California, with their founders, funding, team size and business models.

774 company profiles401 with recorded fundingNovember 2026 edition
San Francisco · Photo: Wikimedia Commons (CC BY-SA 3.0)

Recent life sciences business events in San Francisco

Funding, M&A, contract wins and launches involving 1,084 life sciences companies in San Francisco, last 24 months: 104 funding rounds · 92 M&A deals · 35 Contracts · 2 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.

ContractTechnology

Chai Discovery · client: Pfizer

Pfizer announced a licensing agreement with Chai Discovery that gives it early access to the new Chai-3 AI platform, which could improve its ability to identify and design new drug…

Biopharmaceutical
M&AAcquisition · Announced

Resmed acquires Noctrix health

announces that portfolio company Noctrix Health has been acquired by ResMed (NYSE: RMD), a global leader in sleep health and respiratory care, in a transaction valued at $340 million.

Medical technology
M&AAcquisition · Announced

Innovaccer acquires Caduceushealth

Innovaccer Inc., a leading healthcare AI company, today announced the asset acquisition of CaduceusHealth, a nationally recognized revenue cycle management services provider.

Revenue cycle management services
M&AAcquisition · Announced

Sensei biotherapeutics acquires Faeth therapeutics

Sensei Biotherapeutics reported first-quarter 2026 results and said the quarter was 'transformational,' highlighting the acquisition of Faeth Therapeutics and a concurrent $200 million…

Biotechnology
M&AAcquisition · Announced

Radoff-JEC Group acquires Seer

We are pleased to submit this further improved, non-binding proposal to acquire 100% of the equity of the Company for $2.40 per share in cash, which represents an immediate 42% premium…

M&AAcquisition · Announced

Robo.ai Inc. acquires Neurovia

Robo.ai Inc. (NASDAQ:AIIO) said Thursday it agreed to acquire Neurovia AI Limited, a data processing and compression technology company, in a $100 million all-stock deal aimed at…

Data processing and compression technology
M&AAcquisition · Announced

Bayer acquires Perfuse therapeutics

The Leverkusen take over the US biotech company Perfuse Therapeutics, which specializes in ophthalmology. The deal has a volume of up to 2.45 billion dollars

Biotech
M&AAcquisition · Announced

Ucb acquires Neurona therapeutics

Belgian biopharma UCB is set to take over California-based Neurona Therapeutics for up to $1.15 billion.

Biotech
M&AAcquisition · Completed

Servier acquires Day one biopharmaceuticals

Transaction represents total equity value of approximately $2.5 billion. Servier ... today announced the successful completion of the tender offer to acquire all of the issued and…

Biopharmaceutical
M&AAcquisition · Announced

Ucb acquires Neurona therapeutics

The pharmaceutical group acquires the American Neurona Therapeutics, thus strengthening its portfolio with promising research on a new treatment against epilepsy. The acquisition amount…

Pharmaceutical
ContractTechnology

Aligos therapeutics · client: Xiamen Amoytop Biotech

Aligos Therapeutics has signed an exclusive licence agreement with Xiamen Amoytop Biotech for the development and commercialisation of pevifoscorvir sodium in Greater China for chronic…

Contract

Xiamen Amoytop Biotech · client: Aligos therapeutics

Aligos Therapeutics has signed an exclusive licence agreement with Xiamen Amoytop Biotech for the development and commercialisation of pevifoscorvir sodium in Greater China for chronic…

Pharmaceuticals
FundingPublic offering

Spyre therapeutics

Spyre Therapeutics, Inc. (“Spyre” or the “Company”) announced the pricing of its previously announced underwritten public offering of 6,500,000 shares of its common stock at a price to…

Biotechnology
M&AAcquisition · Announced

Aurinia Pharma acquires Kezar life sciences

Aurina aims to acquire all outstanding shares of Kezar Life Sciences.

FundingPublic offering

Allogene therapeutics

Allogene Therapeutics, Inc. (Nasdaq: ALLO ) today announced that it intends to offer and sell, in an underwritten public offering and subject to market and other conditions, $175 million…

Investors Goldman sachs, Jefferies, Td cowen, TPG Capital BD, LLC
Clinical-stage biotechnology
M&AAcquisition · Announced

Radoff-JEC Group acquires Seer

The Radoff-JEC Group, which owns approximately 7.6% of Seer's outstanding shares, proposed to acquire 100% of the company for $2.25 per share in cash, representing a 33% premium to the…

Proteomics
FundingSeed

Tippingpoint biosciences

Emerging biotechnology company aims to unlock targeting of disease-specific epigenetic protein interfaces to develop next‑generation therapies for pediatric cancers SAN…

Investors Sosv, LKS Fund, Sazze partners, Freeflow Ventures
Biotechnology
M&AAcquisition · Announced

Gilead sciences acquires Ouro Medicines

Gilead recently agreed to buy autoimmune disease–focused Ouro Medicines for $1.7 million up front

Biopharmaceutical
M&AAcquisition · Announced

Aurinia Pharma U.S., Inc. acquires Kezar life sciences

On April 1, 2026, Kezar Life Sciences, Inc. announced that it has entered into an Agreement and Plan of Merger with Aurinia Pharma U.S., Inc. ("Aurinia" or "Parent"), a Delaware…

Pharmaceutical
M&AAcquisition · Announced

Aurinia pharmaceuticals acquires Kezar life sciences

Aurinia Pharmaceuticals announced that it has entered into a definitive merger agreement to acquire Kezar Life Sciences, Inc. for $6.955 in cash per share, along with a contingent value…

Funding

Centivax

Centivax, Inc., a clinical-stage biotechnology company engineering vaccines and therapies for durable, universal protection against highly diverse targets, announced the closing of a $37…

Investors Structure fund, Meiji seika pharma, Sigmas Group, Kendall Capital Partners
Biotechnology
M&AAcquisition · Announced

Aurinia pharmaceuticals acquires Kezar life sciences

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs,…

Biotechnology
Funding

Tempest therapeutics

$2 million upfront with up to approximately $4 million of potential aggregate gross proceeds upon the exercise in full of warrants BRISBANE, Calif., March 23, 2026 (GLOBE NEWSWIRE) --…

Biotechnology
M&AAcquisition · Announced

Biomemory acquires Catalog technologies

Biomemory has acquired selected assets from Catalog Technologies, a pioneer in DNA-based data storage and computing systems.

M&AAcquisition · Announced

GlaxoSmithKline (GSK) acquires Rapt therapeutics

GlaxoSmithKline (GSK) in January committed $2.2 billion to acquire Rapt Therapeutics

Biopharma
M&AAcquisition · Completed

Servier acquires Ideaya biosciences

Last September, Servier paid Ideaya Biosciences $230 million up front for rights outside of the U.S. to darovasertib, which is in late‑stage development for a rare type of eye cancer.

Pharmaceuticals
Funding

Tamarind Bio

Tamarind Bio – $13.6M

Investors Dimension Capital
ContractTechnology

Vir biotechnology · client: Astellas pharma

Astellas Pharma Inc. and Vir Biotechnology Inc. have signed a global co-development pact to advance VIR-5500, Vir’s PRO-XTEN dual-masked CD3 T-cell engager targeting prostate-specific…

Healthcare/Biotechnology

Life sciences companies in San Francisco, by funding and team

Few life sciences companies in San Francisco, California publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 774 active companies.

Showing 25 of 50

AI-enabled platform for drug discovery and development

Life sciences tech
US$1.00bnSeries D · Apr 2024
214LinkedIn · Oct 2026
Subscription
3 yr2023
0none in 3 months · last posted May 2026

Developer of machine learning platform for drug discovery and development

Artificial intelligence
US$643.21mSeries C · Mar 2021
258+55% 12 mo to Dec 2021LinkedIn · Jul 2026
Subscription
8 yr2018
0none in 3 months · last posted Jun 2026

Developer of immune cell therapies for cancer treatment

Oncology
US$631.16mSeries C · Jul 2024
160+91% 12 mo to Dec 2022LinkedIn · Oct 2026
Fee-for-service
7 yr2019
0none in 3 months

Manufacturer of a medical device for cell-based therapy

Life sciences platforms and tools
US$612.00mSeries D · Jan 2026
322+15% vs previous recordLinkedIn · Jul 2026
Fee-for-service
7 yr2019
0none in 3 months · last posted Jun 2026

Developer of healthcare data platforms and artificial intelligence agent software

Big data analytics
US$557.35mSeries F · Jan 2025
1,608LinkedIn · Oct 2026
Subscription
12 yr2014
3postings · last posted Sep 2026

Developer of chimeric antigen receptor cell therapy to treat cancer

Immunotherapy
US$531.77mSeries A · Sep 2018
234+15% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
8 yr2018
0none in 3 months · last posted May 2026

Developer of therapeutics for the treatment of auto-immune disease

Immunology
US$529.00mSeries C · Mar 2024
268LinkedIn · Oct 2026
Subscription
23 yr2003
0none in 3 months · last posted May 2026

Developer of CAR- T therapy for cancer treatment

Immunotherapy
US$493.00mSeries C · Mar 2020
232-18% 12 mo to Dec 2023LinkedIn · Oct 2026
Fee-for-service
8 yr2018
0none in 3 months · last posted Nov 2025

Developer of antibodies to modulate the activity of immunosuppressive cells in the tumor microenvironment

Immunotherapy
US$475.00mSeries D · Jul 2020
23+10% 12 mo to Dec 2022LinkedIn · Jul 2026
Fee-for-service
11 yr2015
0none in 3 months

Provider of a genomic database for clinical research

Healthcare booking platforms
US$435.00mSeries E · Jun 2021
621-57% vs previous recordLinkedIn · Oct 2026
Subscription
11 yr2015
0none in 3 months

Developer of biologics to treat hepatitis B infection

Infectious diseases
US$415.00mSeries D · Mar 2021
84+66% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
8 yr2018
0none in 3 months

Provider of a cloud-based bioinformatics platform for biotech research

Genomics
US$411.90mSeries F · Nov 2021
810+98% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
14 yr2012
0none in 3 months · last posted Jul 2026

Company provides healthcare analytics and value-based payments platform services

Healthcare it
US$410.97mSeries D · Apr 2022
128+87% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
11 yr2015
0none in 3 months

Provider of therapies for metabolic health in chronic disease patients

Healthcare it
US$401.78mSeries E · Apr 2021
906-4% 12 mo to Dec 2023LinkedIn · Oct 2026
Fee-for-service
12 yr2014
0none in 3 months · last posted Jan 2025

Provider of cell-free cancer liquid biopsy test

Genomics
US$388.62mSeries D · Jun 2024
851+114% 12 mo to Dec 2020LinkedIn · Oct 2026
E-commerce - product / Physical commerce
11 yr2015
0none in 3 months · last posted Jun 2026

Developer of biologics for the treatment of cardio-metabolic and liver disease

Gastroenterology
US$358.87mSeries D · Mar 2015
71+7% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
19 yr2007
0none in 3 months

Developer of small-molecule therapeutics for cancer treatment

Oncology
US$358.00mSeries C · Apr 2026
49-3% vs previous recordLinkedIn · Jul 2026
Subscription
5 yr2021
0none in 3 months

Developer of therapies to treat neurodegenerative diseases

Neurology
US$347.00mSeries B · Aug 2016
606+28% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
11 yr2015
0none in 3 months · last posted Mar 2026

Developer of T-cell-based therapies for autoimmune and degenerative diseases

Immunology
US$335.00mSeries B · Aug 2021
66+208% 12 mo to Dec 2021LinkedIn · Jul 2026
Fee-for-service
14 yr2012
0none in 3 months · last posted Jun 2026

Developer of a semiconductor-based DNA synthesis platform

Life sciences platforms and tools
US$320.76mSeries F · Apr 2018
1,312-7% 12 mo to Sep 2023LinkedIn · Oct 2026
Physical commerce
13 yr2013
0none in 3 months · last posted Jun 2026

AI-based drug discovery model for researchers

Life sciences tech
US$310.00mSeries D · Jun 2025
28+142% 12 mo to Dec 2021LinkedIn · Jul 2026
Commission on transaction / E-commerce - product
8 yr2018
0none in 3 months

Developer of an AI platform for discovering and designing novel drugs

Generative ai
US$304.02mSeries B · Nov 2024
170-81% vs previous recordLinkedIn · Jul 2026
Subscription
7 yr2019
0none in 3 months · last posted Oct 2025

Online platform for clinical trail data analytics and management software for researchers

Life sciences tech
US$287.80mSeries E · Jan 2022
173-12% vs previous recordLinkedIn · Jul 2026
Subscription
15 yr2011
0none in 3 months

Developer of therapies for immunological diseases and cancer

Immunology
US$267.00mSeries C · Oct 2025
44LinkedIn · Jul 2026
Physical commerce
8 yr2018
0none in 3 months

All-in-one blood glucose monitoring system

Diabetes
US$258.45mSeries F · May 2019
43+49% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
24 yr2002
0none in 3 months
50 of 774 companies shown here · the full list is on Radar
Fliar Radar

Explore all 774 life sciences companies in San Francisco on Radar

This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.

Open life sciences in San Francisco on Radar
  • Every company, not just 50All 774 life sciences companies in San Francisco, filterable by stage, funding, team size, revenue model and age.
  • Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
  • Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
  • Save and exportBuild lists, compare companies side by side and export them from your Radar account.

Explore life sciences companies in San Francisco by what you are looking for

Find top life sciences companies in San Francisco for science technology, genomics, oncology, and research platforms. Explore life sciences companies in San Francisco by the care and research areas they serve.

7 ways to explore life sciences in San Francisco

Life sciences technology companiesGenomics & clinical diagnostics companiesOncology & cancer treatment companiesLife sciences platforms & research toolsLife sciences startups in San FranciscoLife sciences companies hiring in San Francisco

Life sciences technology companies

Companies building digital tools and technology for life sciences work.

  1. Innovaccer

    Developer of healthcare data platforms and artificial intelligence agent software

    Big data analytics
    See in list
  2. Clarify

    Company provides healthcare analytics and value-based payments platform services

    Healthcare it
    See in list
  3. Virta

    Provider of therapies for metabolic health in chronic disease patients

    Healthcare it
    See in list
  4. Verana Health

    Online platform for clinical trail data analytics and management software for researchers

    Life sciences tech
    See in list
  5. Viz.ai

    Developer of an AI-powered platform for care coordination and disease detection

    Healthcare it
    See in list

Genomics & clinical diagnostics companies

Companies working with genetic data, testing, and clinical diagnostics.

  1. Helix

    Provider of a genomic database for clinical research

    Healthcare booking platforms
    See in list
  2. Inflammatix

    Provider of diagnostic solutions for systemic infections

    Genomics
  3. Invitae

    Provider of home-based genetic test for individuals

    Genomics
  4. Adela

    Developer of a platform for detection of cancer

    Genomics
  5. Mirvie

    Provider of non-invasive diagnostic tests for pregnant women

    Women health

Oncology & cancer treatment companies

Companies developing cancer diagnostics, therapies, and research.

  1. ArsenalBio

    Developer of immune cell therapies for cancer treatment

    Oncology
    See in list
  2. Allogene Therapeutics

    Developer of chimeric antigen receptor cell therapy to treat cancer

    Immunotherapy
    See in list
  3. Lyell Immunopharma

    Developer of CAR- T therapy for cancer treatment

    Immunotherapy
    See in list
  4. Tizona Therapeutics

    Developer of antibodies to modulate the activity of immunosuppressive cells in the tumor microenvironment

    Immunotherapy
    See in list
  5. BillionToOne

    Provider of cell-free cancer liquid biopsy test

    Genomics
    See in list

Life sciences platforms & research tools

Providers of research platforms, laboratory tools, and scientific services.

  1. Cytek Biosciences

    Manufacturer of flow cytometry systems for research applications

    Life sciences platforms and tools
  2. Culture Biosciences

    Provider of biomanufacturing hardware and software tools for research purposes

    Life sciences platforms and tools
  3. Xcell Biosciences

    Developer of cell culture analysis device for cancer research

    Genomics
  4. Stamm Biotech

    Developer of cell processing platforms for research and industries

    Life sciences platforms and tools
  5. Paragon Genomics

    Provider of technologies and solutions genomic research and precision medicine

    Genomics

Life sciences startups in San Francisco

Recently founded life sciences companies in San Francisco.

  1. Xaira

    AI-enabled platform for drug discovery and development

    Life sciences tech
    See in list
  2. Terremoto

    Developer of small-molecule therapeutics for cancer treatment

    Oncology
    See in list
  3. Merge Labs

    Developer of brain-computer interfaces to maximize human ability, agency, experience

    Neurology
    See in list
  4. NewLimit

    Developer of epigenetic reprogramming medicines for aging-related diseases and healthspan extension

    Life sciences tech
    See in list
  5. Chai Discovery

    Developer of artificial intelligence models for de novo molecular design

    Generative ai
    See in list
160 companies in San Francisco

Life sciences companies hiring in San Francisco

Life sciences companies in San Francisco with hiring activity.

  1. Xaira

    AI-enabled platform for drug discovery and development

    Life sciences tech
    See in list
  2. Cellares

    Manufacturer of a medical device for cell-based therapy

    Life sciences platforms and tools
    See in list
  3. Innovaccer

    Developer of healthcare data platforms and artificial intelligence agent software

    Big data analytics
    See in list
  4. Allogene Therapeutics

    Developer of chimeric antigen receptor cell therapy to treat cancer

    Immunotherapy
    See in list
  5. Alumis

    Developer of therapeutics for the treatment of auto-immune disease

    Immunology
    See in list
43 companies in San Francisco

Public life sciences companies in San Francisco

Publicly listed life sciences companies in San Francisco.

  1. Allogene Therapeutics

    Developer of chimeric antigen receptor cell therapy to treat cancer

    Immunotherapy
    See in list
  2. Alumis

    Developer of therapeutics for the treatment of auto-immune disease

    Immunology
    See in list
  3. Lyell Immunopharma

    Developer of CAR- T therapy for cancer treatment

    Immunotherapy
    See in list
  4. Brii Biosciences

    Developer of biologics to treat hepatitis B infection

    Infectious diseases
    See in list
  5. BillionToOne

    Provider of cell-free cancer liquid biopsy test

    Genomics
    See in list
53 companies in San Francisco
Mobile reach

Top 10 life sciences apps from San Francisco

The most-installed Android apps published by life sciences companies headquartered in San Francisco — 6.9M installs between them. 28 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.

1 of 10
1

Academia.edu

by Academia

Installs4.8M
Rating4.7107K ratings
Installs, year on year+10%
Last updatedApr 2026
Academia.edu screenshot 1Academia.edu screenshot 2Academia.edu screenshot 3Academia.edu screenshot 4Academia.edu screenshot 5Academia.edu screenshot 6
2

MDacne - Custom Acne Treatment

by MDacne

Installs700K
Rating4.444K ratings
Last updatedAug 2022
MDacne - Custom Acne Treatment screenshot 1MDacne - Custom Acne Treatment screenshot 2MDacne - Custom Acne Treatment screenshot 3MDacne - Custom Acne Treatment screenshot 4MDacne - Custom Acne Treatment screenshot 5
3

MyZio

by iRhythm Tech

Installs648K
Rating4.6716K ratings
Last updatedMar 2026
MyZio screenshot 1MyZio screenshot 2MyZio screenshot 3MyZio screenshot 4MyZio screenshot 5MyZio screenshot 6
4

Qaly | ECG Reader

by QALY

Installs213K
Rating2.9912 ratings
Installs, year on year+26%
Last updatedApr 2026
Qaly | ECG Reader screenshot 1Qaly | ECG Reader screenshot 2Qaly | ECG Reader screenshot 3Qaly | ECG Reader screenshot 4Qaly | ECG Reader screenshot 5
5

Sunbasket - Meal Kit Delivery

by Sun Basket

Installs152K
Rating4.23K ratings
Installs, year on year+4%
Last updatedApr 2026
Sunbasket - Meal Kit Delivery screenshot 1Sunbasket - Meal Kit Delivery screenshot 2Sunbasket - Meal Kit Delivery screenshot 3Sunbasket - Meal Kit Delivery screenshot 4Sunbasket - Meal Kit Delivery screenshot 5Sunbasket - Meal Kit Delivery screenshot 6
6

Virta Health

by Virta

Installs138K
Rating4.7961 ratings
Installs, year on year+60%
Last updatedJun 2026
Virta Health screenshot 1Virta Health screenshot 2Virta Health screenshot 3Virta Health screenshot 4Virta Health screenshot 5Virta Health screenshot 6
7

Lavita AI

by Lavita

Installs115K
Rating5.083 ratings
Last updatedFeb 2026
Lavita AI screenshot 1Lavita AI screenshot 2Lavita AI screenshot 3Lavita AI screenshot 4Lavita AI screenshot 5
8

LinkBluCon

by Ambrosia

Installs57K
Rating2.54294 ratings
Last updatedDec 2025
LinkBluCon screenshot 1LinkBluCon screenshot 2LinkBluCon screenshot 3LinkBluCon screenshot 4LinkBluCon screenshot 5LinkBluCon screenshot 6
9

kGoal: Smart Kegels

by kGoal

Installs41K
Rating4.24155 ratings
Last updatedJun 2026
kGoal: Smart Kegels screenshot 1kGoal: Smart Kegels screenshot 2kGoal: Smart Kegels screenshot 3kGoal: Smart Kegels screenshot 4kGoal: Smart Kegels screenshot 5kGoal: Smart Kegels screenshot 6
10

kegg

by kegg

Installs26K
Rating3.35133 ratings
Last updatedMar 2026
kegg screenshot 1kegg screenshot 2kegg screenshot 3kegg screenshot 4kegg screenshot 5
RadarBrowse every life sciences company in San Francisco on RadarOpen the full list and use the App Downloads and App Growth filters to keep only companies with a mobile app. This rail shows only the ten most-installed.Browse on Radar
For investors and data teams

Put this intelligence into your own tools

The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.

Capital & corporate activity

Life sciences funding and M&A across the United States

22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how San Francisco compares. Debt, IPO and grant rounds are excluded.

equity rounds, last 12 months360

US$13.54bn

equity rounds, last 24 months1232

US$37.38bn

raised over five yearsUS$157.58bn

5,603 rounds in the United States

M&A deals, San Francisco92

last 24 months

Capital by year

Equity funding into life sciences in the United States

amount rounds
$26bn20181450
$23bn20191352
$32bn20201398
$45bn20211383
$30bn20221075
$22bn20231064
$25bn2024940
$23bn2025850
$12bn2026291

Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.

The funding ladder · five years

Rounds and typical cheque by stage

AngelUS$70.78m18 rounds · median US$1.40m
SeedUS$5.87bn1,808 rounds · median US$1.11m
Series AUS$38.68bn1,753 rounds · median US$8.80m
Series BUS$46.06bn1,089 rounds · median US$23.00m
Series CUS$30.98bn517 rounds · median US$42.00m
Series D+US$35.59bn392 rounds · median US$50.00m
Private equityUS$66.54m22 rounds · median US$14.25m
Where the money went · five years

Most-funded sub-sectors

OncologyUS$24.87bn658 rounds · 368 companies
Life sciences techUS$16.70bn556 rounds · 344 companies
GenomicsUS$15.90bn409 rounds · 249 companies
NeurologyUS$13.39bn445 rounds · 248 companies
ImmunologyUS$12.90bn189 rounds · 111 companies
Life sciences platforms and toolsUS$7.97bn387 rounds · 238 companies
Cardiac and vascular disordersUS$7.63bn313 rounds · 172 companies
Corporate activity · last 24 months

M&A in San Francisco

76Acquisition
14Merger
2Takeover

Most active acquirers

  1. Exelixis5
  2. Mirion technologies4
  3. Alumis4
  4. Innovaccer3
  5. Servier3

Most acquired or merged

  1. 89bio5
  2. Kezar life sciences4
  3. Rapt therapeutics4
  4. Bluejay therapeutics4
  5. Acelyrin4

Each deal appears in the events strip at the top of the page.

Industry landscape report

Life Sciences Industry Landscape of San Francisco

The financials above are one chapter. The full life sciences landscape of San Francisco maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.

  • Market map of every sub-sector
  • Funding & company formation by year
  • Revenue, profit & financial strength
  • Digital footprint: traffic, apps, releases
  • Hiring, skills & pay
  • Founders & leaders
  • News & sentiment
  • Where demand runs ahead of supply
Read the life sciences landscape of San Francisco

Life sciences funding in San Francisco

401 life sciences companies in San Francisco have recorded equity funding, US$28.79bn in total. Totals and round dates describe the historical record; they are not current valuations.

Founders and momentum in San Francisco

Meet the people behind life sciences companies in San Francisco. 585 of 774 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.

Explore San Francisco life sciences companies by sub-sector

The most common specialisations among life sciences companies in San Francisco. Open a company to see what it sells, who runs it and how far it has come.

Keep exploring life sciences in the United States and nearby markets.

Explore more lists: nearby cities and other sectors in San Francisco

258 more company lists you can search, plus the Radar directory pages for each place.

Life sciences in nearby cities

Life sciences in other US cities

Other sectors in San Francisco

Browse the Radar directory

Coming soon